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Abstract. At present time the ultrasound imaging technique is widely used for qualitative 
evaluation of ocular tissue structure. Differential diagnosis of human eye tumors is one of the most 
important problems in ophthalmology in dealing with cancer prevention and diagnostics. Simple 
ultrasonic methods such as A scan and B scan images used in ophthalmology helps to identify 
intraocular tumors, but does not reflect the microstructure, does not allow them to differentiate. In 
this paper the new technique for tumours tissue structure evaluation using ultrasound spectral 
analysis is presented. Based on the obtained results, it can be said that RF ultrasound signals 
parameters (amplitude envelope, spectrum slope, spectrum intercept and momentary bandwidth) 
at the healthy tissue area and the area with the intraocular tumor – melanoma and hemangioma 
statistically are significantly different. This study has shown that the lower amplitude, lower 
spectral intercept, high spectral slope and high momentary bandwidth are typical for choroidal 
melanoma if compared with hemangioma or healthy tissues. This allows us to distinguish healthy 
tissues from the abnormal tumor tissues, to identify and differentiate chorioidal melanoma and 
hemangioma between each other. Application of spectral analysis using non-invasive ultrasound 
expert system, reliably reflects tissue microstructure, gives more information about tissue 
differences, allows to distinguish healthy tissues from the tumor to identify and differentiate 
tumors between each other. 
Keywords: ultrasound, intraocular tumours, spectral analysis, radiofrequency signals. 
1. Introduction 
Intraocular tumors are called tumors of the inner eye coatings. These tumors are dangerous not 
only because of vision loss, but often because of threat for the patient's life. They are usually 
malignant [1-2]. 
Differential diagnosis of eye tumors is one of the most important problems in ophthalmology. 
Eye tumors, especially melanoma are very dangerous due to metastasis to other organs. Malignant 
tumors of the eye makes 0.2 percent of all malignant tumors diagnosed and is every a direct cause 
of death for every third patient [1-2]. 
Early detection of these lesions and accurate diagnosis leads to effective assistance. There are 
several pathologies similar to malignant tumors: choroidal naevus, hemangioma, subretinal 
hemorrhage, exudative macular degeneration, haemophthalmus. Early diagnosis and tissue 
characterization is crucial in order to apply the proper treatment, to predict course of disease and 
to prevent from patient's death [1-2]. 
The most common clinical use study assessing changes in the fundus of the eye is an 
optical-ophthalmoscopy-eye fundus examination and subjective visual evaluation performed with 
optical devices-ophthalmoscopes. This study is not sufficiently informative for differential 
diagnosis of intraocular tumors, because the size and structure of tumor tissue is not being 
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evaluated. Digital optic examination of fundus of the eye and ultrasound methods are used to 
increase informativeness [1-2]. 
Ultrasonic methods stand out in ophthalmology with great informative value among the 
noninvasive methods. This is one of the main diagnostic methods for establishing the diagnosis of 
intraocular tumors [1, 3].  
The first application of diagnostic ultrasound in the eye was reported by Mundt and Hughes in 
1956. Their report described the use of industrial flaw detection equipment for A-mode 
examination of in vitro enucleated eyes and patients with intraocular tumors. Soon afterward, 
Oksala and Lehtinen of Finland described clinical examinations with a handheld A-mode 
transducer. A flurry of activity followed, primarily in Europe and the United States, to develop 
sonographic techniques for biometry, A-mode diagnosis, and B-mode visualization [4]. 
Ultrasound technology has been used in ophthalmology since D. Jackson Coleman, MD, and 
others described its use for the evaluation of ocular pathology in the late 1960s and early 1970s. 
When IOLs began to gain popularity later in the 1970s, cataract surgeons adopted ultrasound 
A-scans to measure the axial length of the eye for IOL power calculation. A-scan biometry became 
more accurate over time, with the addition of gates to take into account changes in the velocity of 
sound as it travels through the different media in the eye [4]. 
Independently, pioneering researchers converged on three important clinical applications of 
highfrequency B-mode imaging: these were in ophthalmology (Pavlin et al. 1990, Sherar et al. 
1989), dermatology (Hoffmann et al. 1989, 1990) and intravascular ultrasound (Bom et al. 1989, 
Meyer et al. 1988, Nissen et al. 1990, Yock et al. 1989). Skin and intravascular applications began 
in the 20 MHz range, and ophthalmic applications centred in the 40 to 60 MHz range. In each case, 
unique instrumentation was created to address the specific needs of the applications. The 
ultrasonic visualisation of living tissue at microscopic resolution is referred to in the literature as 
“ultrasound backscatter microscopy” or “ultrasound biomicroscopy” [4]. 
Ultrasound B-scan image carries information for determination of tumours shape, topography, 
tumour pervasion into the eye fundus Fig. 1 [1]. 
Eye tumour size, shape, present of retina detachment, vascular excavation are determined from 
the B-scan image. Key indicators for intraocular tumor differentiation – geometry of the tumor, 
size, shape – most commonly used in clinical practice, as well as blood flow, biochemical 
parameters and additional information is very important. These are the main parameters for 
clinical decision-making: diagnosis, prognosis and choosing the right tactics for treatment of the 
patient’s [1, 3, 5]. 
 
Fig. 1. B – view of the eye tumour (above), A – echogram (below), T – tumour,  
RD – retinal detachment, CE – choroidal excavation, P – height of tumour,  
R – mean amplitude of reflected signal, B – base of the tumour 
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Simple ultrasonic methods such as A scan and B scan images used in ophthalmology helps to 
identify intraocular tumors, but does not reflect the microstructure, does not allow them to 
differentiate [1-3]. 
To get more information about tumor of the eye and its structure, methods and tools are 
required to obtain qualitatively new and valuable information [1-3]. 
Non-invasive ultrasound expert system is designed – consisting of specialized technical 
equipment – a radio frequency (RF) device to receive and collect RF from the inner eye tumors, 
and advanced software for data processing and parameterization [1-3].  
Application of spectral analysis using non-invasive ultrasound expert system, reliably reflects 
tissue microstructure, allows to distinguish healthy tissues from the tumor, to identify and 
differentiate between each other [1, 6]. 
RF signal supplies a valuable information of a tissue morphology – shape, homogenity and 
structure [1, 3, 5]. 
Spectrum analysis of frequency-dependent backscattered radiofrequency (RF) data has been 
used to characterize tissue microstructures in the diagnosis of prostate cancer, ocular tumors, and 
cardiac abnormalities and to differentiate benign lymph nodes from malignant lymph nodes. It has 
been shown theoretically that the spectral parameters are related to tissue microstructural 
properties (e.g., effective acoustic scatterer size and concentration). Ultrasonic spectral analysis 
with a high frequency transducer has been used to detect microstructural changes induced by 
radiotherapy, photodynamic therapy and chemotherapy in tumor xenografts [7]. 
Spectrum analysis techniques were developed to measure reflective tissue properties over a 
range of frequencies and to quantitatively evaluate subresolution constituents in terms of their 
effective sizes, concentrations, and acoustic impedances. A striking example of this spectrum 
analysis technology was a study of malignant melanomas and detection of microarchitectural 
patterns that recognized lethal patterns with 98 % sensitivity. Other applications include tissue 
layer separation (e.g., choroid and sclera) and the monitoring of subtle changes in tissue 
microstructure induced by such treatment modalities as radiotherapy and intense therapeutic 
ultrasound [7]. 
The main parameters reflecting the structure of tumor is the amplitude envelope of RF signal, 
spectral slope, spectral intercept and the momentary bandwidth calculated after spectral analysis. 
2. Objectives of the study 
1. Collect ultrasound images and RF signals for comparative evaluation between healthy eye 
tissues and tissues with intraocular tumors: chorioidal melanoma and hemangioma.  
2. The aim of this research is to compare parameters of ultrasound signals backscattered from 
healthy ocular tissues with intraocular tumor suspicious tissues using spectrum analysis of 
frequency-dependent backscattered radiofrequency (RF) for intraocular tumor characterization in 
vivo.  
3. Methods and data 
The study involved 30 people from 18 to 80 years attending in Hospital of Lithuanian 
University of Health Sciences Kaunas Eye Clinics consultation diagnostic department with 
suspected or diagnosed intraocular eye tumor – choroidal melanoma – 30 cases, with hemangioma 
– 12 cases and 60 cases with healthy eyes.  
In both eyes of control group, the two ROI (rectangular regions of interest) were sellected and 
used to check if healthy tissues are similar statistically. In the eye with suspicious tissues two 
manners of ROI selections were done: selecting both ROI at the same direction of Bscan vector 
(b) and selecting each ROI at diferent Bscan vector (c) Fig. 2. Using these to types of tissues 
imaging could lead to the possility to check if parameters of backscattered signals from healthy 
tissues are influenced by acoustic properties of suspicious tissues.  
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Fig. 2. ROI selection in B scan images of the eye: a) in eyes of control group;  
b) in suspicious eyes in one direction; c) in suspicious eyes in two directions.  
1 – healthy tissue; 2 – plus tissue 
All subjects underwent a detailed ophthalmic examination. Optical transparent assessment 
with a slit lamp. Eye fundus was photographed with digital ophtalmoscope Optomed Smartscope 
M3 – 1 data was stored in databases. 
Ultrasound examination of eye of subjects was performed for evaluation of intraocular tissue 
structural parameters.The hardware and software system used for acquisition of ultrasound B scan 
raw signals is described by R. Jurkonis and co. in [8]. Briefly the hardware system could be 
specified as follow. The ultrasound B scan system is Mentor (Advent, Norwell, MA), with 
mechanical scanning transducer of 12 MHz, this original system is supplemented with signal 
acquisition system [9, 10]. System assures acquisition of raw ultrasound diagnostic signals with 
250 MHz sampling frequency and 8 bits amplitude resolution. B scan raw signals were stored into 
database on computer hard disc and analyzed off-line. Analysis was performed by ophthalmologist 
using NICDIT v1.2 software. B scan raw signals were loaded into software reviewed and two 
regions of interest were selected manually. Both regions were of the same length (1.5 mm) in all 
analyzed cases. Example B scan images with selected regions are presented in Fig. 3. Two areas 








Fig. 3. ROI selection in one direction of B scan images: a) in healthy (control) eye (id221);  
b) in melanoma eye (id176); c) in heamangioma eye (id288) 
The raw RF signals from selected regions were analysed in NICDIT v1.2 software algorithms.  
Radiofrequency row signals where characterized with four parameters: signal envelope 
amplitude (V), intercept (dB) momentary bandwidtht (MHz) and slope (dB/MHz) of 
approximated backscattered spectra. The amplitude of a radio frequency echo signal distribution 
equals to the sum of the signals from each reflecting point in the radiation line. Power spectrum 
of the echo signal is calculated using the discrete Fourier transformation. 
After analysis the noninvasive ultrasound tissue characterizing parameters were saved into 
reports. They were compared by applying amplitude and spectral analysis of raw Bscan signals.  
Then parameters matrix was analyzed statistically if there is correlation with intraocular tissue 
structure. 
The statistical analysis was performed using the computer program SPSS v17.0. For 
comparison of differences of quantitative values for two independent groups a Student-normal 
distribution and the Mann-Whitney test was used. Differences are estimated as statistically 
significant when ܲ < 0.05. 
1444. APPLICATION OF ULTRASOUND SPECTRAL ANALYSIS FOR INTRAOCULAR TISSUES DIFFERENTIATION.  
JURGIS TRUMPAITIS, RYTIS JURKONIS, DAIVA IMBRASIENĖ, AGNĖ GRIZICKAITĖ, ALVYDAS PAUNKSNIS 
3590 © JVE INTERNATIONAL LTD. JOURNAL OF VIBROENGINEERING. NOV 2014, VOLUME 16, ISSUE 7. ISSN 1392-8716  
4. Results of ultrasound tissue characterization.  
Preliminary conclusions can be made after study of 30 cases with intraocular choroidal 
melanoma and 12 with hemangioma, all compared with healthy tissue area of 60 cases.  
Distribution of patients by sex in 30 cases of melanoma group was 11 men and 19 women.  
Average age was 60,1 years. In 12 cases of hemangioma group there were 9 women and 3 men, 
average age was 65 years. In control group there were 30 cases with both eyes – 19 men and 11 
women, average age was 48,3 years. 
In melanoma group the mean visual acuity (VA) in 27 patients was 0,35, the mean best visual 
acuity (BCVA) was 0,45. 3 patients had only light perception. In hemangioma group the mean 
VA was 0,3, BCVA was 0,5. In control group the mean VA was 0,77 and BCVA was 0,98. 
The mean intraocular pressure (IOP) in melanoma and hemangioma group was the same – 
14,7 mmHg. In control group – 16,7 mmHg.  
Results of B scan showed that the mean basis of melanoma tumor was 11,3 mm and the mean 
height was 5,1 mm. In hemangioma tumor – respectively 7,7 mm and 2,7 mm. 
4.1. Amplitude 
The comparison of amplitude in exploratory groups revealed that there is no significant 
difference between the healthy tissue 0,054 V and melanoma tumor in all directions. The 
statistically significant difference was revealed between the healthy tissue and the hemangioma 
tumor amplitude in different directions 0,083 V (݌ < 0,05) Fig. 4. 
 
Fig. 4. Mean amplitude of healthy tissues in different groups 
The comparison of amplitude in plus tissue zone between groups revealed statistical significant 
difference was between healthy tissues 0,054 V and melanomas in one 0,032 V and in different 
directions 0,028 V (݌ < 0,05). Also significant difference of amplitude was between healthy tissue 
0,054 V and hemangioma group but only in different directions 0,037 V (݌ < 0,05). 
Within melanoma group there was no significant difference between amplitude of one 0,032 
V and different directions 0,028 V.  
Significant difference of amplitude was detected between melanoma and hemangioma groups, 
while comparing melanoma in one 0,032 V and different directions 0,028 V with hemangioma in 
one direction 0,041 V (݌ < 0,05) Fig. 5. 
 
Fig. 5. Mean amplitude of plus tissues amplitude in different groups 
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4.2. Spectral intercept and slope 
The comparison of mean spectral intercept between plus healthy zone and exploratory groups 
revealed the statistically significant difference between healthy tissue (–10,88 dB) and melanoma group 
(in one direction –20,87 dB and in different directions –22,95 dB) and also between healthy tissue and 
hemangioma group (in one direction –17,05 dB and different directions –19,25 dB) (݌ < 0,05). 
Statistically different results were revealed between melanoma and hemangioma groups, 
comparing the mean spectral intercept of melanoma tumor in different directions –22,95 dB and 
the mean spectral intercept of hemangioma tumor in one –17,05 dB and different directions  
–19,25 dB (݌ < 0,05). 
Also statistically different result was in comparison of melanoma tumor mean spectral 
intercept in one direction –20,87 dB and in hemangioma tumor mean spectral intercept in one 
direction –17,05 dB (݌ < 0,05) Fig. 6. 
 
Fig. 6. Mean spectral intercept of plus tissues in different groups 
The comparison of mean spectral slope in plus healthy tissue zone and exploratory groups the 
statistically significant difference was detected. Comparing healthy tissue –1,95 dB/MHz and 
melanoma tumor mean spectral slope in one direction –1,47 dB/MHz and in different directions  
–1,43 dB/MHz. Also healthy tissues –1,95 dB/MHz and hemangioma tumor mean spectral slope 
in one direction –1,59 dB/MHz and in different directions –1,57 dB/MHz (݌ < 0,05). 
There significant difference was found between the groups of melanoma tumor mean spectral 
slope in different directions –1,43 dB/MHz and hemangioma tumor mean spectral slope in one 
direction –1,59 dB/MHz (݌ < 0,05) Fig. 7. 
 
Fig. 7. Mean spectral slope of plus tissues in different groups 
4.3. Momentary bandwidth 
The results of comparison of mean momentary bandwidth in plus healthy tissues zone and 
exploratory groups were statistical different: in healthy group 1,04 MHz and melanoma group in 
one direction 1,75 MHz and in different directions 1,96 MHz. Also in healthy tissue 1,04 MHz 
and hemangioma tumor in different direction 1,57 MHz (݌ < 0,05). 
There was significant difference between groups of melanoma tumor mean momentary 
bandwidth in different directions 1,96 MHz and hemangioma tumor mean momentary bandwidth 
in one direction 1,47 MHz (݌ < 0,05) Fig. 8. 
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Fig. 8. Mean spectral bandwidth of plus tissues in different groups 
The tissues characterising parameters, defined as mean and standard deviation in whole ROIs, 
extracted from RF ultrasound signals are presented in Table 1. 
Table 1. Differentiation parameters (mean, std. deviation)  
of Bscan ultrasound signals backscattered from intraocular tissues 
Parameters 















dB 0,054±0,02 0,032±0,02 0,028±0,01 0,041±0,02 0,037±0,02 
Spectral intercept, 
dB –10,88±0,2 –20,87±0,23 –22,95±0,21 –17,05±0,24 –19,25±0,24 
Spectral slope, 
dB/MHz –1.95±3,53 –1.47±5,4 –1.43±5,84 –1.59±6,94 –1.57±7,31 
Spectral momentary 
bandwidth MHz 1,04±0,21 1,75±0,9 1,96±0,91 1,47±0,90 1,57±1,1 
5. Discussion 
The raw ultrasonic signals backscattered from intraocular tissues were processed and analyzed 
aiming to characterize healthy and suspicious tissues. The signals from selected regions of the eye 
tissues are characterized with parameters: Bscan envelope amplitude (V), approximated spectral 
slope (dB/MHz), approximated spectral intercept (dB) and momentary bandwidth (MHz). The 
interpretation of calculated parameters is hard without final and confirmed clinical diagnosis.  
There are not enough comprehensive studies that compare exploratory groups using spectral 
analysis parameters. A statistical significant difference is detected within exploratory groups and 
within spectral analysis parameters using Stjudent T criteria. 
In Coleman et al. study there were investigated 63 clinical cases that were divided into three 
groups: melanomas group (19 cases), metastatic carcinomas group (24 cases) and 
mixed/epithelioid cells group (20 cases). Spectral analysis parameters (intercept, means of 
amplitude and slope) of groups were compared using Sjtudents T criteria. Significant difference 
was detected in all groups within all spectral parameters (݌ < 0,05) [11]. 
Results showed that rising spectral intercept and low amplitude in the middle rate reflect 
spindle cells melanoma. The high amplitude and low rates reflect carcinoma [11]. 
Spectral parameters are important for monitoring patients, comparing survival rate while using 
different therapies. Spectral analysis method was used in clinical trials for investigation of prostate, 
liver, vascular and breast tissues [12]. 
Mortality rate of melanoma significantly depends on the histological structure [11]. 
Non-invasive ultrasound system which measures spectral analysis parameters (intercept, 
amplitude and slope) helps to differentiate histological structure of the tumor [11]. 
Our study has shown that the lower amplitude, lower spectral intercept, high spectral slope and 
high momentary bandwidth are typical for choroidal melanoma if compared with hemangioma or 
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healthy tissues. This allows us to distinguish healthy tissues from the abnormal tumor tissues and 
also to identify and differentiate chorioidal melanoma from hemangioma. 
6. Conclusions 
1. The obtained results show that there is statistically significant difference between the RF 
ultrasound signal parameters (amplitude envelope, spectrum slope, spectrum intercept and 
momentary bandwidth) in the healthy tissue area and in the area with the intraocular tumor – 
melanoma and hemangioma (݌ < 0,05).  
2. This study has shown that the lower amplitude, lower spectral intercept, high spectral slope 
and high momentary bandwidth are typical for choroidal melanoma if compared with hemangioma 
or healthy tissues.  
3. Non-invasive ultrasound expert system provides the new opportunities in early diagnosis 
and differentiation of tumors – chorioidal melanoma from hemangioma, observation of the process, 
evaluation of the treatment effectiveness as well as prognosis of survival. 
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